• Zevra Therapeutics granted stock options covering 92,200 common shares to four newly hired employees under its 2023 Employment Inducement Award Plan.
• Awards vest over four years, with 25% vesting on the first anniversary of each employee’s start date.
• Remaining options vest in three equal annual installments, subject to continued employment on each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zevra Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608211630PRIMZONEFULLFEED9814219) on August 21, 2026, and is solely responsible for the information contained therein.